“Safety of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus”. KYAMC Journal 16, no. 3 (June 11, 2026): 119–122. Accessed July 7, 2026. https://www.banglajol.info/index.php/KYAMCJ/article/view/88022.